Form 4 for NAMS NewAmsterdam Pharma Co N.V.
Accepted 2026-01-09 00:00:00 ET · period of report 2026-01-07 · accession 0001193125-26-009271 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-01-09 | 2026-01-07 | NAMS | Lewis William | Dir | A - Grant | — | +3,400 | 10.4K | +49% | — |
| D | 2026-01-09 | 2026-01-07 | NAMS | Lewis William | Dir | A - Grant | $0.00 | +15.3K | 15.3K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2026-01-07 | A | A | 3,400 | — | 10,360 | D | — | — | (F1) Represents restricted stock units (RSUs), each representing a contingent right to receive one ordinary share. All of the RSUs will vest on the one-year anniversary of the vesting start date, subject to the Reporting Person's continued service through such date. (F2) Each RSU was granted on January 7, 2026 for no consideration. |
| 2 | Derivative | Option (right to buy) | 2026-01-07 | A | A | 15,300 | $0.00 | 15,300 | D | $35.45 · — to 2036-01-07 | 15,300 Ordinary Shares | (F3) All of the ordinary shares underlying the option will vest on January 2, 2027, the one-year anniversary of the vesting start date, subject to the Reporting Person's continued service through such date. |